BioLineRx Ltd. (BLRX) vs CalciMedica Inc. (CALC)

BioLineRx Ltd. and CalciMedica Inc. are both Biotechnology companies. BioLineRx Ltd. and CalciMedica Inc. are of similar size ($12.6M and $11.9M). CalciMedica Inc. has the higher net margin (0.00% vs −502.1%) and the higher return on invested capital (0.00% vs −74.3%). Across the 14 metrics below, BioLineRx Ltd. leads on 8 and CalciMedica Inc. on 6.

Valuation

Metric BLRX CALC Biotechnology median
P/E n/m n/m 7.88
P/S 8.14 n/m 11.47
P/B 0.68 1.09 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.05 0.74
EV/Sales 3.55 n/m 10.73
Earnings yield (66.27%) (385.71%) (28.84%)
Free cash flow yield (95.69%) (318.85%) (23.03%)

Profitability

Metric BLRX CALC Biotechnology median
Gross margin 80.03% 0.00% 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (365.70%) (57.72%)
Return on assets (18.21%) (110.10%) (49.22%)
Return on invested capital (74.28%) 0.00% 0.00%

Growth

Metric BLRX CALC Biotechnology median
Revenue growth (TTM) (91.93%) — 5.64%
EPS growth (last fiscal year) 93.72% (61.48%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX CALC Biotechnology median
Debt to equity 0.40 1.67 0.00
Current ratio 1.20 5.58 4.73
Net debt to EBITDA 1.22 0.14 0.96

Dividend

Metric BLRX CALC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BLRX CALC Biotechnology median
Market cap 12.55m 11.88m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack